共 50 条
- [1] MITOMYCIN-C, VINBLASTINE AND CISPLATIN (MVP) CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG-CANCER (NSCLC) BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S132 - S132
- [2] DOSE INTENSITY VERSUS TOXICITY TRIAL IN NON-SMALL CELL LUNG-CANCER (NSCLC) WITH MVP (MITOMYCIN (M) + VINBLASTINE (V) + CISPLATIN (P)) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 218 - 218
- [5] COMBINATION CHEMOTHERAPY WITH IFOSFAMIDE, MITOMYCIN, AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG-CANCER CANCER TREATMENT REPORTS, 1987, 71 (09): : 851 - 853
- [6] COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER WITH DOXORUBICIN AND MITOMYCIN OR CISPLATIN AND ETOPOSIDE CANCER TREATMENT REPORTS, 1984, 68 (09): : 1079 - 1084
- [7] COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C, CISPLATIN, AND VINBLASTINE IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (06): : 341 - 345
- [8] CISPLATIN, VINBLASTINE AND BLEOMYCIN (PVB) FOR INOPERABLE NON-SMALL CELL LUNG-CANCER (NSCLC) MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (03): : 155 - 155